BI 163538 XX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 163538 XX, covering 2013-10-31 to 2013-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX [Phase 1]